EPISODE · May 18, 2025 · 18 MIN
MYOPIA May 2025: Atropine and DIMS Lens Combination for Myopia Control
from Eye Research Deep Dive: Doctopus the Octometrist · host Dr Michael Nelson, OD FAAO
Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results of a randomised controlled trial for myopia control using a combination of Defocus Incorporated Multiple Segments (DIMS) lenses and 0.025% atropineGuemes-Villahoz N, Talavero González P, Porras-Ángel P, Bella-Gala R, Ruiz-Pomeda A, Martin-Garcia B, Hernandez-Garcia E, Gomez de Liaño N, Shah R, Garcia-Feijoo J, Gomez-de-Liaño R. Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results of a randomised controlled trial for myopia control using a combination of Defocus Incorporated Multiple Segments (DIMS) lenses and 0.025% atropine. Br J Ophthalmol. 2025 May 9:bjo-2024-326852. doi: 10.1136/bjo-2024-326852. Epub ahead of print. PMID: 40345841.https://bjo.bmj.com/content/bjophthalmol/early/2025/05/08/bjo-2024-326852.full.pdf
NOW PLAYING
MYOPIA May 2025: Atropine and DIMS Lens Combination for Myopia Control
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m